BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27575676)

  • 1. A survey of the use of propranolol in burn centers: Who, what, when, why.
    LeCompte MT; Rae L; Kahn SA
    Burns; 2017 Feb; 43(1):121-126. PubMed ID: 27575676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to burn center referral criteria: are patients appropriately being referred?
    Carter JE; Neff LP; Holmes JH
    J Burn Care Res; 2010; 31(1):26-30. PubMed ID: 20061833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the effect of propanolol on hypermetabolism in burn injuries.
    Núñez-Villaveirán T; Sánchez M; Millán P; García-de-Lorenzo A
    Med Intensiva; 2015 Mar; 39(2):101-13. PubMed ID: 25305241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of medication administration from 2001 to 2009 in the treatment of children with acute burn injuries: a multicenter study.
    Stoddard FJ; White GW; Kazis LE; Murphy JM; Sorrentino EA; Hinson M; Kim Stubbs T; Chan G; Sheridan RL; Palmieri T; Kagan R; Herndon D; Tompkins RG
    J Burn Care Res; 2011; 32(5):519-28. PubMed ID: 21811176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
    Kumar MG; Coughlin C; Bayliss SJ
    Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of propranolol in wound healing for hospitalized burn patients.
    Mohammadi AA; Bakhshaeekia A; Alibeigi P; Hasheminasab MJ; Tolide-ei HR; Tavakkolian AR; Mohammadi MK
    J Burn Care Res; 2009; 30(6):1013-7. PubMed ID: 19826272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient presentations to burn centers: data from the Burns Registry of Australia and New Zealand outpatient pilot project.
    Gabbe BJ; Watterson DM; Singer Y; Darton A
    Burns; 2015 May; 41(3):446-53. PubMed ID: 25540884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population.
    Ojeda S; Blumenthal E; Stevens P; Andersen CR; Robles L; Herndon DN; Meyer WJ
    J Burn Care Res; 2018 Oct; 39(6):963-969. PubMed ID: 29757441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a standardised UK care pathway resulting in national variations in management and outcomes of paediatric small area scalds.
    Trevatt AE; Kirkham EN; Allix B; Greenwood R; Coy K; Hollén LI; Young AE
    Burns; 2016 Sep; 42(6):1241-56. PubMed ID: 27156791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults.
    Ali A; Herndon DN; Mamachen A; Hasan S; Andersen CR; Grogans RJ; Brewer JL; Lee JO; Heffernan J; Suman OE; Finnerty CC
    Crit Care; 2015 May; 19(1):217. PubMed ID: 25936635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of burn depth at burn centers in the United States: a survey.
    Resch TR; Drake RM; Helmer SD; Jost GD; Osland JS
    J Burn Care Res; 2014; 35(6):491-7. PubMed ID: 25144808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
    Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
    Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is propranolol of benefit in pediatric burn patients?
    Finnerty CC; Herndon DN
    Adv Surg; 2013; 47():177-97. PubMed ID: 24298851
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study.
    Herndon DN; Rodriguez NA; Diaz EC; Hegde S; Jennings K; Mlcak RP; Suri JS; Lee JO; Williams FN; Meyer W; Suman OE; Barrow RE; Jeschke MG; Finnerty CC
    Ann Surg; 2012 Sep; 256(3):402-11. PubMed ID: 22895351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of invasive catheter practices in U.S. burn centers.
    Sheridan RL; Neely AN; Castillo MA; Shankowsky HA; Fagan SP; Chung KK; Weber JM
    J Burn Care Res; 2012; 33(6):741-6. PubMed ID: 23147213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Propranolol in Accelerating Wound Healing and Attenuation of Hypermetabolism in Adult Burn Patients.
    Cheema SA; Ahmed UT; Nasir H; Dogar SR; Mustafa Z
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):46-50. PubMed ID: 31931932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion in burns: what do we do?
    Palmieri TL; Greenhalgh DG
    J Burn Care Rehabil; 2004; 25(1):71-5. PubMed ID: 14726742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.
    Orrey DC; Halawa OI; Bortsov AV; Shupp JW; Jones SW; Haith LR; Hoskins JM; Jordan MH; Bangdiwala SI; Roane BR; Platts-Mills TF; Holmes JH; Hwang J; Cairns BA; McLean SA
    Clin J Pain; 2015 Jan; 31(1):21-9. PubMed ID: 25084070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in Burn Excision and Grafting: A Survey of the American Burn Association.
    Israel JS; Greenhalgh DG; Gibson AL
    J Burn Care Res; 2017; 38(1):e125-e132. PubMed ID: 27893575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Flammacerium in British Burns Units.
    Garner JP; Heppell PS
    Burns; 2005 May; 31(3):379-82. PubMed ID: 15774299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.